The 2022 Inflation Reduction Act introduced modest drug pricing restrictions. In response, big pharma companies — which have seen record profits — are threatening to slow the rollout of a lifesaving drug.
I don’t totally blame them because money is needed for research. But if pricing control is done across the board, nobody in particular is being targeted. It doesn’t seem anticompetitive if they are all subject to the same rules. Society needs medicine, but it needs to be affordable. Is it really a cure if people can’t afford it?
A single payer system seems the only way to leverage prices to a point where they are available to everyone. There will be bullying by business, but it’s what we need. If they slow walk something, another company can beat them to it. Let them be merciless to themselves.
I don’t totally blame them because money is needed for research. But if pricing control is done across the board, nobody in particular is being targeted. It doesn’t seem anticompetitive if they are all subject to the same rules. Society needs medicine, but it needs to be affordable. Is it really a cure if people can’t afford it?
A single payer system seems the only way to leverage prices to a point where they are available to everyone. There will be bullying by business, but it’s what we need. If they slow walk something, another company can beat them to it. Let them be merciless to themselves.